Search

The patent application titled "Canine Antibody Libraries" describes the development of the first fully synthetic canine antibody libraries for biomedical research. These libraries contain specific germline VH and VL regions that have been selected for their advantageous properties. The libraries can be screened using methods like phage display to identify antibodies that have an affinity for target molecules. This development is significant as therapeutic monoclonal antibodies have shown promise in improving the treatment of diseases in both humans and dogs. The patent application also includes claims for nucleic acid molecules, vectors, recombinant host cells, and methods for isolating antibodies. This information may be valuable for researchers in the fields of genetics, immunology, and veterinary medicine. [Extracted from the article]